All Cancer Microbiology articles – Page 3
-
NewsPlant fungus provides colorectal cancer drug with a new cellular target
A compound derived from a plant fungus effectively kills colorectal cancer cells by attacking the enzyme DCTPP1, which thus may serve as a potential biomarker for colorectal cancer and a therapeutic target.
-
NewsBacterial vaccine shows promise as cancer immunotherapy
Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
-
NewsNew bacteria-based therapy shows promise for fighting cancer
Researchers have developed a novel method to enhance the cancer-killing properties of bacteria residing in tumors.
-
NewsIn beer yeast, scientists find potential path to starving cancer
The discovery of a surprising way yeast used to brew beer can survive starvation could open the door to new treatments for cancer. The never-before-seen adaptation helps yeast cells go dormant when nutrients are scarce.
-
NewsFermented black garlic extract shows promise against prostate cancer
Researchers test the protective effect of a fermented black garlic extract against inflammation and the progression of prostate cancer in a study conducted on human prostate cancer cell models in the laboratory.
-
NewsChronic stress accelerates colorectal cancer progression by disrupting balance of gut microbiota
Cutting-edge research has uncovered how chronic stress disrupts the balance of gut microbiota to speed up the progression of colorectal cancer (CRC), opening new avenues for CRC prevention and treatment.
-
NewsZika virus offeres potential as treatment for brain cancer: review
Fourteen studies showed that Zika virus reduced cell viability, inhibited the growth and proliferation of glioma stem cells (GSCs), and decreased Bcl2 expression in central nervous system tumors, potentially enhancing chemotherapy and radiotherapy effects.
-
NewsHibernating ribosomes flip upside down in starving yeast cells
Scientists have discovered a curious way in which cells adapt to starvation – a mechanism with potential cancer implications.
-
NewsScientists engineer new enzyme to produce synthetic genetic material
Researchers have engineered an efficient new enzyme that can produce a synthetic genetic material called threose nucleic acid. The ability to synthesize artificial chains of TNA advances the discovery of therapeutic options to treat cancer and other diseases.
-
NewsMouse model clarifies link between prostate cancer and gut bacteria
Researchers have investigated whether a mouse model of the disease can be used to explore the underlying mechanisms behind the relationship of changes in the composition of gut bacteria and the risk and progression of prostate cancer.
-
NewsGut bacteria engineered to act as tumor GPS for immunotherapies
Cancer researchers have engineered gut derived E. coli bacteria to express immune-activating cytokines on their surfaces, with the idea that the bacteria would move into tumors and induce potent immune responses.
-
NewsFerring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
Ferring Pharmaceuticals launches state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin® (nadofaragene firadenovec-vncg), an adenovirus vector-based gene therapy.
-
NewsGut microbiome and tumor cachexia: New European research network
EU project ‘MiCCrobioTAckle’ aims to investigate the complex interactions between the gut microbiome and the human body in order to find ways of slowing down muscle breakdown in tumor cachexia, while promoting young scientists for microbiota medicine.
-
NewsCircadian disruption and gut microbiome changes linked to colorectal cancer progression
Research has revealed how disruption of the circadian clock, the body’s internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function.
-
NewsBacteria involved in gum disease linked to increased risk of head and neck cancer
More than a dozen bacterial species among the hundreds that live in people’s mouths have been linked to a collective 50% increased chance of developing head and neck squamous cell carcinoma (HNSCC), a new study shows. Some of these microbes had previously been shown to contribute to ...
-
NewsFecal DNA testing could reduce global colonoscopy burden: experts
Experts gathered at the ICG 19 · Metagenomics for Health (ICG19·MH) & The 2nd MOHA Consortium have highlighted the global challenge of limited access to colonoscopy, the gold standard for CRC screening.
-
News‘Transient’ gut bacteria may affect health and guide diet choices
‘Transient’ populations of gut bacteria may contribute to the development of chronic liver disease and diabetes, but a personalised diet plan could lessen the risk, new research suggests.
-
NewsGut bacteria influence responses to immunotherapy in patients with asbestos related cancer
A cancer study has found that certain gut bacteria may influence whether or not a patient’s immune system is successful in fighting mesothelioma, an aggressive form of cancer.
-
NewsSkin fungus colonization accelerates breast cancer tumor growth
A common skin fungus, Malassezia globosa may invade deep tissues through the skin or by other means, then cause tumor growth, according to a new study.
-
NewsFirst narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study
Scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes.